Načítá se...
miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics
Glioblastoma (GBM) is an incurable cancer, with survival rates of just 14-16 months after diagnosis.(1) Functional genomics have identified numerous genetic events involved in GBM development. One of these, the deregulation of microRNAs (miRNAs), has been attracting increasing attention due to the m...
Uloženo v:
| Vydáno v: | Cell Cycle |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825743/ https://ncbi.nlm.nih.gov/pubmed/26506113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2015.1093711 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|